Evidence map›Paper›PMID 42169994›Full record

ArticleJournal of human immunity2026

Hematopoietic stem cell transplantation following invasive mold infection in chronic granulomatous disease: Insights from a case series and literature review.

Hugo Bes-Berlandier, Olivier Paccoud, Benedicte Neven, Marie Elisabeth Bougnoux, Emilie Sitterlé, Ambroise Marcais, Morgane Cheminant, Despina Moshous, Rinzine Sammut, Pierre Simon Rohrlich and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of human immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hugo Bes-BerlandierUniversité Paris Cité, Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Paris, France.ORCID https://orcid.org/0009-0007-8881-9414
Olivier PaccoudUniversité Paris Cité, Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Paris, France.ORCID https://orcid.org/0000-0002-3975-3136
Benedicte NevenPediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID https://orcid.org/0000-0001-8941-0935
Marie Elisabeth BougnouxUniversité Paris Cité, Service de Mycologie-Parasitologie, Hôpital Necker-Enfants Malades, Paris, France.ORCID https://orcid.org/0000-0003-4721-2740
Emilie SitterléUniversité Paris Cité, Service de Mycologie-Parasitologie, Hôpital Necker-Enfants Malades, Paris, France.ORCID https://orcid.org/0009-0001-6141-1845
Ambroise MarcaisUniversité Paris Cité, Service D'hématologie Adultes, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID https://orcid.org/0000-0002-6844-7920
Morgane CheminantUniversité Paris Cité, Service D'hématologie Adultes, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID https://orcid.org/0000-0002-2070-9581
Despina MoshousUniversité Paris Cité, Service D'hématologie Adultes, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID https://orcid.org/0000-0001-6719-3693
Rinzine SammutService D'hématologie Clinique, Centre Hospitalier Universitaire de Nice, Nice, France.ORCID https://orcid.org/0000-0003-3015-0846
Pierre Simon RohrlichService D'hématologie Clinique, Centre Hospitalier Universitaire de Nice, Nice, France.ORCID https://orcid.org/0000-0001-8801-4164
Nizar MahlaouiPediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID https://orcid.org/0000-0002-0030-8094
Olivier LortholaryUniversité Paris Cité, Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Paris, France.ORCID https://orcid.org/0000-0002-8325-8060
Felipe SuarezUniversité Paris Cité, Service D'hématologie Adultes, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID https://orcid.org/0000-0002-3537-9052
Fanny LanternierUniversité Paris Cité, Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Paris, France.ORCID https://orcid.org/0000-0003-3800-4683

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic granulomatous disease (CGD) is an inborn error of immunity leading to severe invasive mold infections (IMIs). Questions remain regarding the safety of hematopoietic stem cell transplantation (HSCT) in patients following IMI. We retrospectively collected data from CGD patients undergoing HSCT within 2 years after a diagnosis of probable or proven IMI in France. The primary endpoint was to describe 1-year overall survival (OS). 14 patients were included, with aspergillosis (

Identifiers

PMID42169994
PMCPMC13177795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.